Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AMOR 1

Drug Profile

AMOR 1

Alternative Names: AMOR-1; Amorphous calcium carbonate (ACC) - Amorphical; Nanoparticulate amorphous calcium carbonate - Amorphical

Latest Information Update: 03 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Amorphical
  • Class Anti-inflammatories; Antineoplastics; Osteoporosis therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hypoparathyroidism
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Hypoparathyroidism
  • Phase II Pancreatic cancer
  • Clinical Phase Unknown Crohn's disease; Osteoporosis

Most Recent Events

  • 24 Nov 2025 Phase-II clinical trials in Pancreatic cancer (Late-stage disease) in Israel (PO) prior to September 2025
  • 24 Nov 2025 The Helsinki Committee of Shaare Zedek Medical Center and the Israel Ministry of Health approves a phase II trial for AMOR 1 in Pancreatic cancer
  • 30 Sep 2025 Clinical trials in Crohn's disease (Adjunctive treatment) in Israel (PO) prior to September 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top